| MD | SB496 | Pass | Authorizing, beginning January 1, 2027, the Maryland Medical Assistance Program to provide comprehensive coverage for the treatment of obesity; requiring the Maryland Department of Health to provide notice to Program recipients if the Department elec...
[Detail][Text][Discuss] | 2026-05-31
Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 866 |
| MD | SB532 | Pass | Requiring each public senior higher education institution and community college to submit a report on contraception access to the Maryland Higher Education Commission each year by September 1; requiring the Commission to submit a report on contracept...
[Detail][Text][Discuss] | 2026-05-26
Approved by the Governor - Chapter 675 |
| MD | HB1076 | Pass | Requiring each public senior higher education institution and community college to submit a report on contraception access to the Maryland Higher Education Commission each year; requiring the Commission to submit a report on contraception access to t...
[Detail][Text][Discuss] | 2026-05-26
Approved by the Governor - Chapter 674 |
| MD | SB839 | Pass | Requiring, beginning in 2026, the Maryland Department of Health to conduct the in-State cost-of-dispensing survey at least every 3 years; and requiring by December 1 each year in which the survey is required, the Department to report the survey resu...
[Detail][Text][Discuss] | 2026-05-26
Approved by the Governor - Chapter 708 |
| MD | HB1470 | Pass | Requiring, beginning in 2026, the Maryland Department of Health to conduct the in-State cost-of-dispensing survey at least every 3 years; and requiring the Department to report the results of the survey to the General Assembly by December 1 in each ...
[Detail][Text][Discuss] | 2026-05-26
Approved by the Governor - Chapter 709 |
| MD | HB422 | Pass | Adding bacterial vaginosis to the list of diagnoses for which certain health care practitioners may prescribe, dispense, or otherwise provide antibiotic therapy to a sexual partner of a diagnosed patient without making a personal physical assessment ...
[Detail][Text][Discuss] | 2026-04-28
Approved by the Governor - Chapter 194 |
| MD | HB427 | Pass | Extending to December 31, 2027, the Task Force on Responsible Use of Natural Psychedelic Substances to study and make recommendations related to the use of natural psychedelic substances; adding a representative of a historically Black college or uni...
[Detail][Text][Discuss] | 2026-04-28
Approved by the Governor - Chapter 207 |
| MD | SB336 | Pass | Extending to December 31, 2027, the Task Force on Responsible Use of Natural Psychedelic Substances to study and make recommendations related to the use of natural psychedelic substances; adding a representative of a historically Black college or uni...
[Detail][Text][Discuss] | 2026-04-28
Approved by the Governor - Chapter 208 |
| MD | SB394 | Pass | Adding bacterial vaginosis to the list of diagnoses for which certain health care practitioners may prescribe, dispense, or otherwise provide antibiotic therapy to a sexual partner of a diagnosed patient without making a personal physical assessment ...
[Detail][Text][Discuss] | 2026-04-28
Approved by the Governor - Chapter 193 |
| MD | SB423 | Pass | Prohibiting a research facility or a testing facility from using certain dogs and cats for research or testing purposes; prohibiting a research facility or testing facility from performing devocalization procedures on dogs or cats; prohibiting a test...
[Detail][Text][Discuss] | 2026-04-28
Approved by the Governor - Chapter 230 |
| MD | SB778 | Pass | Establishing a clinical research pharmacy permit; authorizing the State Board of Pharmacy to issue a clinical research pharmacy permit; authorizing a health care provider to hold an ownership interest in a clinical research pharmacy under certain cir...
[Detail][Text][Discuss] | 2026-04-28
Approved by the Governor - Chapter 206 |
| MD | HB1377 | Pass | Establishing the Redirecting Safe Prescription Drugs Pilot Program; requiring the Secretary of Health to collaborate with the federal Drug Enforcement Agency and certain drop-off sites in the State to separate and redirect certain prescription medica...
[Detail][Text][Discuss] | 2026-04-28
Approved by the Governor - Chapter 243 |
| MD | SB159 | Pass | Requiring the Executive Director of the Maryland Institute for Emergency Medical Services Systems to coordinate, with Jurisdictional Emergency Medical Services Operating Programs, the minimum equipment, supplies, and medications needed for early chil...
[Detail][Text][Discuss] | 2026-04-28
Approved by the Governor - Chapter 282 |
| MD | HB838 | Pass | Authorizing licensed certified midwives to enter into therapy management contracts; repealing a requirement that authorized prescribers submit prescriber-pharmacist agreements to the health occupations board that regulates the authorized prescriber; ...
[Detail][Text][Discuss] | 2026-04-14
Approved by the Governor - Chapter 53 |
| MD | SB562 | Pass | Authorizing licensed certified midwives to enter into therapy management contracts; repealing a requirement that authorized prescribers submit prescriber-pharmacist agreements to the health occupations board that regulates the authorized prescriber; ...
[Detail][Text][Discuss] | 2026-04-14
Approved by the Governor - Chapter 54 |
| MD | HB417 | Engross
Sine Die | Establishing medetomidine and xylazine as Schedule III controlled dangerous substances under the Maryland Controlled Dangerous Substances Act
[Detail][Text][Discuss] | 2026-04-13
Motion Special Order until Next Session (Senator Love) Adopted |
| MD | SB435 | Intro
Sine Die | Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer f...
[Detail][Text][Discuss] | 2026-04-13
Motion Laid Over (Senator Ready) Adopted |
| MD | HB666 | Engross
Sine Die | Prohibiting a research facility or a testing facility from using certain dogs and cats for research or testing purposes; prohibiting a research facility or testing facility from performing devocalization procedures on dogs or cats; prohibiting a test...
[Detail][Text][Discuss] | 2026-04-13
To Senate Education, Energy, and the Environment Committee |
| MD | HB1426 | Engross
Sine Die | Establishing a clinical research pharmacy permit; authorizing the State Board of Pharmacy to issue a clinical research pharmacy permit; authorizing a health care provider to hold an ownership interest in a clinical research pharmacy under certain cir...
[Detail][Text][Discuss] | 2026-04-13
To Senate Rules Committee |
| MD | HB813 | Engross
Sine Die | Authorizing, beginning January 1, 2027, the Maryland Medical Assistance Program to provide comprehensive coverage for the treatment of obesity; requiring the Maryland Department of Health to provide notice to Program recipients if the Department elec...
[Detail][Text][Discuss] | 2026-04-09
House Conference Committee Appointed (Delegates Hill, Martinez and Hutchinson) |
| MD | SB284 | Pass | Altering or repealing certain required appropriations; authorizing the use of certain funds for certain purposes; authorizing, requiring, or altering the distribution of certain revenue; authorizing the Secretary of Health to establish the retention ...
[Detail][Text][Discuss] | 2026-04-08
Approved by the Governor - Chapter 6 |
| MD | SB608 | Engross
Sine Die | Requiring, beginning July 1, 2027, the Maryland Medical Assistance Program and certain health insurers, nonprofit health services plans, and health maintenance organizations to provide coverage for single-gene and multigene pharmacogenomic testing in...
[Detail][Text][Discuss] | 2026-03-25
To House Health Committee |
| MD | HB279 | Engross
Sine Die | Authorizing the establishment of a medication review committee within the Department of Public Safety and Correctional Services that convenes to determine whether to approve the administration of psychotropic medication to a certain incarcerated indi...
[Detail][Text][Discuss] | 2026-03-23
To Senate Judicial Proceedings Committee |
| MD | HB639 | Engross
Sine Die | Requiring certain aeronautical service providers that service a flight with detained individuals to request to see a warrant for the detained individual, and to note whether there is a warrant and the type of warrant; requiring certain aeronautical s...
[Detail][Text][Discuss] | 2026-03-23
To Senate Finance Committee |
| MD | HB1112 | Engross
Sine Die | Altering the duties of the Health Insurance Coverage Protection Commission to require the Commission to study and make recommendations regarding individual and group health insurance market stability.
[Detail][Text][Discuss] | 2026-03-20
To Senate Finance Committee |
| MD | HB1558 | Intro
Sine Die | Establishing a licensing and regulatory system for anesthesiologist assistants under the State Board of Physicians.
[Detail][Text][Discuss] | 2026-03-18
To House Health Committee |
| MD | HB1380 | Intro
Sine Die | Requiring insurers, nonprofit health service plans, and health maintenance organizations to provide coverage for a certain supply of prescription drugs used for gender-affirming care, hormone therapy, or reproductive health in certain circumstances; ...
[Detail][Text][Discuss] | 2026-03-13
To House Health Committee |
| MD | HB1440 | Intro
Sine Die | Prohibiting a managed care organization and certain insurers, nonprofit health service plans, and health maintenance organizations from requiring a prior authorization or step therapy or fail-first protocol under certain circumstances for prescriptio...
[Detail][Text][Discuss] | 2026-03-13
Withdrawn by Sponsor |
| MD | HB1461 | Intro
Sine Die | Altering the circumstances under which certain insurers, nonprofit health service plans, and health maintenance organizations are prohibited from excluding coverage for certain specialty drugs for the treatment of rheumatologic conditions.
[Detail][Text][Discuss] | 2026-03-13
To House Health Committee |
| MD | HB1435 | Intro
Sine Die | Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to provide certain coverage for hormone-related care, including hormone therapy treatment for perimenopausal and menopausal symptoms; establishing certai...
[Detail][Text][Discuss] | 2026-03-13
To House Health Committee |
| MD | HB1565 | Intro
Sine Die | Requiring the Secretary of Budget and Management to include a certain obesity management and treatment program in the State Employee and Retiree Health and Welfare Benefits Program; establishing requirements for the obesity management and treatment p...
[Detail][Text][Discuss] | 2026-03-13
To House Health Committee |
| MD | HB520 | Engross
Sine Die | Altering the drugs that may be prescribed, provided, or administered or for which a starter dose may be dispensed by a naturopathic doctor; repealing the Naturopathic Doctors Formulary Council; altering the methods by which a naturopathic doctor may ...
[Detail][Text][Discuss] | 2026-03-12
To Senate Finance Committee |
| MD | HB1417 | Intro
Sine Die | Repealing the requirement that a person have a certain permit before the person carries, wears, or transports a handgun; repealing certain criminal prohibitions against a person who is at least 21 years old wearing, carrying, or transporting a handgu...
[Detail][Text][Discuss] | 2026-03-11
To House Judiciary Committee |
| MD | SB987 | Intro
Sine Die | Providing an addition modification under the corporate income tax for the amount of certain direct-to-consumer advertising expenses for certain covered drugs paid or incurred during the taxable year that are deducted under the Internal Revenue Code; ...
[Detail][Text][Discuss] | 2026-03-05
To Senate Budget and Taxation Committee |
| MD | HB1045 | Intro
Sine Die | Altering the circumstances under which the Prescription Drug Monitoring Program is required to disclose prescription monitoring data to a federal law enforcement agency to prohibit the disclosure if the Protected Health Care Commission determines tha...
[Detail][Text][Discuss] | 2026-03-03
Withdrawn by Sponsor |
| MD | SB951 | Intro
Sine Die | Establishing a licensing and regulatory system for anesthesiologist assistants under the State Board of Physicians.
[Detail][Text][Discuss] | 2026-03-02
To Senate Finance Committee |
| MD | HB1629 | Intro
Sine Die | Requiring the Maryland Department of Health to establish by regulation standards relating to the discharge of patients from drug and alcohol treatment programs and certain referral services offered to patients by certain drug and alcohol treatment pr...
[Detail][Text][Discuss] | 2026-02-25
To House Rules and Executive Nominations Committee |
| MD | HB1564 | Intro
Sine Die | Prohibiting a person doing business in the State from knowingly manufacturing or selling, distributing, dispensing, or otherwise supplying a drug or medical device or compounding a drug if the person knows or reasonably should know certain authorizat...
[Detail][Text][Discuss] | 2026-02-20
To House Judiciary Committee |
| MD | HB808 | Intro
Sine Die | Prohibiting the Maryland Medical Assistance Program from applying a prior authorization requirement in certain circumstances to and from applying a step therapy or fail-first protocol for a prescription drug used to treat an adult enrollee's diagnosi...
[Detail][Text][Discuss] | 2026-02-19
To House Health Committee |
| MD | HB696 | Intro
Sine Die | Authorizing certain retirees who began State service before July 1, 2011, to be eligible for prescription drug benefits in the State Employee and Retiree Health and Welfare Benefits Program; specifying that prescription drug benefits shall be discont...
[Detail][Text][Discuss] | 2026-02-17
To House Appropriations Committee |
| MD | HB1502 | Intro
Sine Die | Authorizing the sale and possession of certain consumer fireworks, subject to certain requirements and restrictions; altering certain provisions to establish that certain provisions authorizing the State Fire Marshal to issue a certain permit relatin...
[Detail][Text][Discuss] | 2026-02-17
To House Economic Matters Committee |
| MD | HB88 | Intro
Sine Die | Authorizing certain insurers, nonprofit health service plans, and health maintenance organizations to join bulk purchasing pools for prescription drugs.
[Detail][Text][Discuss] | 2026-02-16
Withdrawn by Sponsor |
| MD | HB1542 | Intro
Sine Die | Prohibiting a person doing business in the State from knowingly manufacturing or selling, distributing, dispensing, or otherwise supplying a drug, medical device, or other good, service, or technology or compounding a drug if the person knows or reas...
[Detail][Text][Discuss] | 2026-02-16
To House Judiciary Committee |
| MD | HB515 | Intro
Sine Die | Requiring that the hospital representative on a local drug overdose fatality review team be a vice president, a chief medical officer, or an assistant medical officer at the hospital.
[Detail][Text][Discuss] | 2026-02-13
To House Health Committee |
| MD | HB1162 | Intro
Sine Die | Requiring the Special Secretary of Overdose Response to provide funding to counties for medication-assisted treatment programs; requiring certain counties to submit a certain report; authorizing the Governor to include in the annual budget bill an ap...
[Detail][Text][Discuss] | 2026-02-13
To House Health Committee |
| MD | HB1133 | Intro
Sine Die | Requiring drug manufacturers and certain patient advocacy organizations to register with the Maryland Department of Health before conducting a disease awareness campaign in the State; and requiring that materials produced and distributed as part of a...
[Detail][Text][Discuss] | 2026-02-13
To House Health Committee |
| MD | HB1134 | Intro
Sine Die | Prohibiting sellers of certain pharmaceutical drugs and devices from giving or offering to give to health care professionals gifts in a calendar year that have a total combined retail value of more than $50.
[Detail][Text][Discuss] | 2026-02-13
To House Health Committee |
| MD | HB1451 | Intro
Sine Die | Requiring the Maryland Department of Health to develop and implement a standard system to collect and compile annual data on the costs of prenatal care, birth, postpartum care, pregnancy care, abortion services, and menopausal care in the State; esta...
[Detail][Text][Discuss] | 2026-02-13
To House Health Committee |
| MD | HB1469 | Intro
Sine Die | Requiring the Maryland Insurance Administration to convene a workgroup to study a certain definition of specialty drug in a certain manner and make a recommendation to the Governor and the General Assembly by January 1, 2027, for a new definition of ...
[Detail][Text][Discuss] | 2026-02-13
To House Health Committee |
| MD | HB1477 | Intro
Sine Die | Establishing the Ibogaine Clinical Research Grant Program to provide grants to certain research institutions to conduct certain clinical drug development trials on the use of ibogaine; and including the Program as an authorized use of funding from th...
[Detail][Text][Discuss] | 2026-02-13
To House Health Committee |
